New research suggests neuroimaging is an emerging technique that has the potential to aid treatment of mental health disorders. Scientists believe looking into the brain will yield vital clues to understanding, diagnosing and treating bipolar disorder.
Two new studies have identified patterns of abnormalities in the neural systems that underlie emotional processing and cognitive control unique to the bipolar brain.
The first study, by Husseini K. Manji, M.D., chief of the Laboratory of Molecular Pathophysiology at the National Institute of Mental Health (NIMH), suggests that bipolar disorder arises from abnormalities in neuronal plasticity cascades – the complex machinery inside of nerve cells that regulates numerous processes inside the body.
Using animal and cellular models, Dr. Manji and colleagues at NIMH showed that disruptions in these pathways resulted in many of the core symptoms of bipolar disorder and explained many other observations about the disease.
The findings suggest a new avenue for treating the underlying cause of bipolar, rather than treating flare-ups of depression or mania, and also provide new targets, for improved medications many of which are being tested in clinical trials.
Using neuroimaging, Mary Phillips, M.D., has identified patterns of abnormalities in the neural systems that underlie emotional processing and cognitive control unique to the bipolar brain.
Such abnormalities are valuable biomarkers for the illness and have the potential to help clinicians diagnose bipolar disorder earlier and more efficiently.
Dr. Phillips has identified how imaging can be used to identify biomarkers and how these markers can help clinicians determine which patients will respond best to certain treatments.
Further, the use of neuroimaging to help predict which patients of those who are genetically predisposed to bipolar disorder will develop symptoms of the disease can be a significant adjunct to the treatment of the disorder.